RayzeBio Common Stock Statistics
Share Statistics
RayzeBio Common Stock has 60.02M
shares outstanding. The number of shares has increased by 0%
in one year.
| Shares Outstanding | 60.02M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 69,419 |
| FTD / Avg. Volume | 9.31% |
Short Selling Information
The latest short interest is 847.93K, so 1.41% of the outstanding
shares have been sold short.
| Short Interest | 847.93K |
| Short % of Shares Out | 1.41% |
| Short % of Float | 1.48% |
| Short Ratio (days to cover) | 2.86 |
Valuation Ratios
The PE ratio is -13.72 and the forward
PE ratio is null.
RayzeBio Common Stock's PEG ratio is
-0.1.
| PE Ratio | -13.72 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | -8.46 |
| P/FCF Ratio | -15.49 |
| PEG Ratio | -0.1 |
Financial Ratio HistoryEnterprise Valuation
RayzeBio Common Stock has an Enterprise Value (EV) of 822.68M.
| EV / Sales | 0 |
| EV / EBITDA | -11.65 |
| EV / EBIT | -15.92 |
| EV / FCF | -13.53 |
Financial Position
The company has a current ratio of 28.69,
with a Debt / Equity ratio of -0.09.
| Current Ratio | 28.69 |
| Quick Ratio | 28.69 |
| Debt / Equity | -0.09 |
| Debt / EBITDA | -0.15 |
| Debt / FCF | -0.17 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is 61.64% and Return on Invested Capital is 71.6%.
| Return on Equity | 61.64% |
| Return on Assets | -21.12% |
| Return on Invested Capital | 71.6% |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-779,545.45 |
| Employee Count | 88 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 0% in the
last 52 weeks. The beta is 3.79, so RayzeBio Common Stock's
price volatility has been higher than the market average.
| Beta | 3.79 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 61.51 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 88.25 |
| Average Volume (20 Days) | 745,490 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -72.12M |
| Net Income | -68.6M |
| EBITDA | -70.59M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -1.75 |
Full Income StatementBalance Sheet
The company has 129.16M in cash and 10.57M in
debt, giving a net cash position of 118.59M.
| Cash & Cash Equivalents | 129.16M |
| Total Debt | 10.57M |
| Net Cash | 118.59M |
| Retained Earnings | -130.12M |
| Total Assets | n/a |
| Working Capital | n/a |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -51.68M
and capital expenditures -9.1M, giving a free cash flow of -60.78M.
| Operating Cash Flow | -51.68M |
| Capital Expenditures | -9.1M |
| Free Cash Flow | -60.78M |
| FCF Per Share | -1.55 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
